In this work we study the effect of the HDAC inhibitor Entinostat (MS275), which is already in clinical trials for cancer treatment, on hepatic lipid metabolism in HepaRG cells by quantifying lipid store droplets and their distribution at single cell level utilizing a label-free microscopy technique, coherent anti-Stokes Raman scattering (CARS). Here, HDAC9 is linked to cancer.